FDA
-
-
-
-
-
-
-
Kyowa Kirin begins phase 2 trial of ziftomenib in Japan for AML
-
-
-
-
-
-
-
Amgen and Kyowa Kirin report one-year rocatinlimab safety data
-
-
-
-
-
-
-
Kura Oncology (KURA) and Kyowa Kirin announce abstract on ziftomenib trial
-
-
-
-
-
-
-
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
-
-
-
-
-
-
-
Kyowa Kirin to end distribution of Fareston (toremefine) in the United States
-
-
-
-
-
-
-
Kyowa Kirin to Acquire Orchard Therapeutics
-
-
-
-
-
-
-
MEI Pharma and Kyowa Kirin Announce Acceptance of Three Abstracts for Presentation at the American Society of Hematology Annual Meeting 2022
-
335,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


